Difference between revisions of "Template:Adrenergics"
From Self-sufficiency
m |
|||
| Line 13: | Line 13: | ||
| group2 = [[α2-adrenergic receptor|α<sub>2</sub>]] | | group2 = [[α2-adrenergic receptor|α<sub>2</sub>]] | ||
| − | | list2 = '''Agonists''': [[(R)-3-Nitrobiphenyline]]{{•}} [[4-NEMD]]{{•}} [[6-Fluoronorepinephrine|6-FNE]]{{•}} [[Amitraz]]{{•}} [[Apraclonidine]]{{•}} [[Brimonidine]]{{•}} [[Clonidine]]{{•}} [[Detomidine]]{{•}} [[Dexmedetomidine]]{{•}} [[Dihydroergotamine]]{{•}} [[Dipivefrine]]{{•}} [[Dopamine]]{{•}} [[Ephedrine]]{{•}} [[Ergotamine]]{{•}} [[Epinephrine]] (Adrenaline){{•}} [[Esproquin]]{{•}} [[Etilefrine]]{{•}} [[Ethylnorepinephrine]]{{•}} [[Guanabenz]]{{•}} [[Guanfacine]]{{•}} [[Guanoxabenz]]{{•}} [[Levonordefrin]]{{•}} [[Lofexidine]]{{•}} [[Medetomidine]]{{•}} [[Methyldopa]]{{•}} [[Mivazerol]]{{•}} [[Naphazoline]]{{•}} [[Norepinephrine]] (Noradrenaline){{•}} [[Phenylpropanolamine]]{{•}} [[Piperoxan]]{{•}} [[Pseudoephedrine]]{{•}} [[Rilmenidine]]{{•}} [[Romifidine]]{{•}} [[Talipexole]]{{•}} [[Tetrahydrozoline]]{{•}} [[Tizanidine]]{{•}} [[Tolonidine]]{{•}} [[Urapidil]]{{•}} [[Xylazine]]{{•}} [[Xylometazoline]]<br/>'''Antagonists''': [[Pyrimidinylpiperazine|1-PP]]{{•}} [[Adimolol]]{{•}} [[Aptazapine]]{{•}} [[Atipamezole]]{{•}} [[BRL-44408]]{{•}} [[Buflomedil]]{{•}} [[Cirazoline]]{{•}} [[Efaroxan]]{{•}} [[Esmirtazapine]]{{•}} [[Fluparoxan]]{{•}} [[GYKI-12,743]]{{•}} [[GYKI-16,084]]{{•}} [[Idazoxan]]{{•}} [[Mianserin]]{{•}} [[Mirtazapine]]{{•}} [[MK-912]]{{•}} [[NAN-190]]{{•}} [[Olanzapine]]{{•}} [[Phentolamine]]{{•}} [[Phenoxybenzamine]]{{•}} [[Piperoxan]]{{•}} [[Piribedil]]{{•}} [[Rauwolscine]]{{•}} [[Rotigotine]]{{•}} [[SB-269,970]]{{•}} [[Setiptiline]]{{•}} [[Spiroxatrine]]{{•}} [[Sunepitron]]{{•}} [[Tolazoline]]{{•}} [[Yohimbine]]<br/><small>* Note that many [[atypical antipsychotic]]s and [[azapirone]]s like [[buspirone]] and [[gepirone]] (via metabolite [[Pyrimidinylpiperazine|1-PP]]) antagonize α<sub>2</sub>-adrenergic receptors as well.</small> | + | | list2 = '''Agonists''': [[(R)-3-Nitrobiphenyline]]{{•}} [[4-NEMD]]{{•}} [[6-Fluoronorepinephrine|6-FNE]]{{•}} [[Amitraz]]{{•}} [[Apraclonidine]]{{•}} [[Brimonidine]]{{•}} [[Clonidine]]{{•}} [[Detomidine]]{{•}} [[Dexmedetomidine]]{{•}} [[Dihydroergotamine]]{{•}} [[Dipivefrine]]{{•}} [[Dopamine]]{{•}} [[Ephedrine]]{{•}} [[Ergotamine]]{{•}} [[Epinephrine]] (Adrenaline){{•}} [[Esproquin]]{{•}} [[Etilefrine]]{{•}} [[Ethylnorepinephrine]]{{•}} [[Guanabenz]]{{•}} [[Guanfacine]]{{•}} [[Guanoxabenz]]{{•}} [[Levonordefrin]]{{•}} [[Lofexidine]]{{•}} [[Medetomidine]]{{•}} [[Methyldopa]]{{•}} [[Mivazerol]]{{•}} [[Naphazoline]]{{•}} [[Norepinephrine]] (Noradrenaline){{•}} [[Phenylpropanolamine]]{{•}} [[Piperoxan]]{{•}} [[Pseudoephedrine]]{{•}} [[Rilmenidine]]{{•}} [[Romifidine]]{{•}} [[Talipexole]]{{•}} [[Tetrahydrozoline]]{{•}} [[Tizanidine]]{{•}} [[Tolonidine]]{{•}} [[Urapidil]]{{•}} [[Xylazine]]{{•}} [[Xylometazoline]]<br/>'''Antagonists''': [[Pyrimidinylpiperazine|1-PP]]{{•}} [[Adimolol]]{{•}} [[Aptazapine]]{{•}} [[Atipamezole]]{{•}} [[BRL-44408]]{{•}} [[Buflomedil]]{{•}} [[Cirazoline]]{{•}} [[Efaroxan]]{{•}} [[Esmirtazapine]]{{•}} [[Fenmetozole]]{{•}} [[Fluparoxan]]{{•}} [[GYKI-12,743]]{{•}} [[GYKI-16,084]]{{•}} [[Idazoxan]]{{•}} [[Mianserin]]{{•}} [[Mirtazapine]]{{•}} [[MK-912]]{{•}} [[NAN-190]]{{•}} [[Olanzapine]]{{•}} [[Phentolamine]]{{•}} [[Phenoxybenzamine]]{{•}} [[Piperoxan]]{{•}} [[Piribedil]]{{•}} [[Rauwolscine]]{{•}} [[Rotigotine]]{{•}} [[SB-269,970]]{{•}} [[Setiptiline]]{{•}} [[Spiroxatrine]]{{•}} [[Sunepitron]]{{•}} [[Tolazoline]]{{•}} [[Yohimbine]]<br/><small>* Note that many [[atypical antipsychotic]]s and [[azapirone]]s like [[buspirone]] and [[gepirone]] (via metabolite [[Pyrimidinylpiperazine|1-PP]]) antagonize α<sub>2</sub>-adrenergic receptors as well.</small> |
| group3 = [[β-adrenergic receptor|β]] | | group3 = [[β-adrenergic receptor|β]] | ||
Revision as of 01:12, 20 September 2010
Lua error in package.lua at line 80: module 'Module:Color contrast' not found.
